Medical/Pharmaceuticals

Holmusk and NHCS Extend Collaboration to Improve Heart Disease Care

SINGAPORE, Dec. 23, 2019 /PRNewswire/ -- Holmusk and National Heart Centre Singapore announced that they have extended their collaboration agreement to improve care for patients with coronary artery disease using machine learning and data analytics, untilDecember 2020. This will build upon the wo...

2019-12-23 13:43 572

iView Announces First Patient Treated in Phase 2 Clinical Trial Program Evaluating IVIEW-1201 in Patients with Acute Adenoviral Conjunctivitis

HYDERABAD, India, Dec. 23, 2019 /PRNewswire/ -- iView Therapeutics Inc. today announced that the first patient has been dosed in the Phase 2 IVIEW-1201-01-AIC clinical trial program assessing the efficacy of IVIEW-1201 in patients (age ≥15 years) with Acute Adenoviral Conjunctivitis. First subjec...

2019-12-23 08:42 516

NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study

LUND, Sweden, Dec. 23, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the completed recruitment of healthy volunteers in the second part of the company's ongoing Phase Ia/b clinical study with candidate drug KL1333, in development for chroni...

2019-12-23 08:33 408

InxMed Receives Approval to Initiate Phase I Clinical Trial in China for IN10018

BEIJING, Dec. 20, 2019 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced today that the Company has obtained IND (Investigational New Drug) clearan...

2019-12-20 18:21 429

Hematogenix Announces the Opening of Their Newest Facility in Shanghai, China

TINLEY PARK, Illinois, Dec. 19, 2019 /PRNewswire/ -- Hematogenix® announces the opening of their newest facility inShanghai, China furthering their commitment to be a global leader in the field of cancer research and diagnostic testing. China's growing population is attractive to the pharmaceutica...

2019-12-19 22:07 557

4G Clinical Launches Innovative Clinical Supply Software Leveraging Natural Language Processing (NLP)

4C Supply™ Empowers Supply Professionals to Build and Analyze Multiple Supply Models Themselves, Providing Speed, Simplicity and Control over Supply Decisions WELLESLEY, Mass., Dec. 19, 2019 /PRNewswire/ -- 4G Clinical today announced the launch of 4C Supply™, a cutting-edge clinical supply optim...

2019-12-19 21:20 646

Merck Licenses Foundational CRISPR Integration Technology to Promega

- Gives scientists a new view into natural cell activity, accelerating drug development DARMSTADT, Germany, Dec. 19, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that it has signed a license agreement providingPromega Corp., a global life science manufact...

2019-12-19 21:00 692

Tessa Therapeutics to Open 90,000 Square Foot Commercial-Scale Cell Therapy Manufacturing Facility in Singapore in 2020

* State-of-the-art manufacturing facility will support clinical and commercial production of cell therapies for thousands of patients annually worldwide * Global commercial-scale facility is designed to comply with cGMP guidelines in the U.S.,Europe and Asia * Facility will integrate digita...

2019-12-19 20:00 432

Getinge to Acquire Applikon Biotechnology B.V., A Leading Company in the Fast Growing Area of Bioreactor Systems

GOTHENBURG, Sweden, Dec. 19, 2019 /PRNewswire/ -- Getinge announces today an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V. Applikon Biotechnology B.V. is a leading company in the fast growing area of advanced bioreactor systems for...

2019-12-19 18:27 14077

Pentax Medical Remains Committed to Endoscopic Ultrasound Business

TOKYO, Dec. 19, 2019 /PRNewswire/ -- PENTAX Medical continues its commitment to Endoscopic Ultrasound (EUS) as an indispensable part of its flexible endoscopy portfolio. The recent launch of the PENTAX Medical EUS/EBUS-J10* line-up is experiencing unmatched recognition by the endoscopy community....

2019-12-19 16:14 448

Asieris Wins Questex's Fierce Innovation Awards - Life Sciences Edition 2019

SHANGHAI, Dec. 19, 2019 /PRNewswire/ -- Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, announced today that it has been selected as a winner in this year's Fierce Innovation ...

2019-12-19 13:51 393

health.ESDlife Enlightens Your Healthy Living with Diversified Offerings

HONG KONG, Dec. 18, 2019 /PRNewswire/ -- An e-commerce brand of ESDlife, under the umbrella of renowned multinational conglomerate CK Hutchison Holdings Limited (SEHK: 0001),health.ESDlife (https://health.esdlife.com/ ) Hong Kong's first and only online platf...

2019-12-18 19:22 456

Amaris B. Clinic Medical Director: Gynecomastia is Prevailing in Older Men, Especially Those Taking Prescription Medications

SINGAPORE, Dec. 18, 2019 /PRNewswire/ -- Dr Ivan Puah, the medical director of Amaris B. Clinic, who has been performing gynecomastia since 2005 and is accredited by the Ministry ofSingapore to perform surgical body sculpting treatments such as liposuction, is seeing an uprise in older male patie...

2019-12-18 19:12 401

Mayapada Healthcare Group named Indonesia Emerging Hospital of the Year by Frost & Sullivan

SINGAPORE, Dec. 18, 2019 /PRNewswire/ -- Mayapada Healthcare Group was recognized with the 2019 Frost & Sullivan Indonesia Emerging Hospital of the Year award at the annual Frost & Sullivan Asia-Pacific Best Practices Awards banquet held at The St. Regis Singapore on 14 November. Norazah Bachok,...

2019-12-18 14:54 411

Össur Celebrates 20 Years as a Publicly Traded Company

President and CEO Jon Sigurdsson Rings Nasdaq Closing Bell on December 16 NEW YORK, Dec. 18, 2019 /PRNewswire/ -- To mark Össur's 20th anniversary as a publicly traded company,Jon Sigurdsson, the company's President and CEO, rang the closing bell at the Nasdaq MarketSite inNew York's Times Squar...

2019-12-18 03:26 6273

MoA Technology implements CDD Vault to manage its crop protection research data

SAN FRANCISCO and OXFORD, England, Dec. 17, 2019 /PRNewswire/ -- MoA Technology Ltd (MoA Tech) and Collaborative Drug Discovery, Inc (CDD) announced today that MoA Tech teams are successfully running CDD Vault, a comprehensive informatics platform for archiving, mining and analysing chemistry and...

2019-12-17 17:00 477

Great Eastern Takaful Berhad partners DoctorOnCall to offer Harapan Trio customers revolutionary digital healthcare services

KUALA LUMPUR, Malaysia, Dec. 17, 2019 /PRNewswire/ -- After a successful launch of Harapan Trio Campaign inSeptember 2019, Great Eastern Takaful Berhad is now partnering online healthcare provider, DoctorOnCall to offer additional benefits to its Harapan Trio customers. Customers can now enjoy co...

2019-12-17 08:00 527

Pivotal DREAMM-2 study demonstrated a clinically meaningful overall response rate with belantamab mafodotin (GSK2857916) for patients with relapsed/refractory multiple myeloma

* Overall response rate (ORR) of 31% with 2.5 mg/kg regimen and no new safety signals in heavily pre-treated patient population who were refractory to an immunomodulatory drug and a proteasome inhibitor, and were refractory or intolerant to an anti-CD38 antibody * Data published in The Lancet...

2019-12-17 07:47 6737

UTSA Opens Call for Entries for $4 Million Oskar Fischer Prize to Expand Understanding and Explanation of Alzheimer's Disease

SAN ANTONIO, Dec. 17, 2019 /PRNewswire/ -- Today, The University of Texas at San Antonio (UTSA) announced that the official call for entries has opened for the Oskar Fischer Prize to expand the understanding and explanation of Alzheimer's disease. Entries for the prize can be submitted throughDec...

2019-12-17 00:05 398

NeuroVive Announces Settlement in Dispute With CicloMulsion AG

LUND, Sweden, Dec. 16, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) announced today that it has fully and finally settled the dispute with CicloMulsion AG regarding certain pharmaceutical technology. In 2004, NeuroVive entered into a License Agreement wi...

2019-12-16 18:33 4929
12345678 ... 144